Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at danielp ...

A U.S. district judge said he will vacate a declaration by Kennedy that asserted gender-affirming care for young trans people does not meet medical standards of care.

A group of autism scientists kicked off efforts Thursday to influence Congress, and the research agendas of private organizations.

Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in ...

Democrats are laying out their plans to rebuild the health care system in the hopes of eventually regaining control of ...

A nationwide STAT survey of NIH-funded researchers reveals that, a year after Donald Trump's return to the White House, many ...

Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in ...

Chris Klomp, a top official at the federal health department, offered a reality check on President Trump’s drug discount platform, TrumpRx, while speaking at a STAT event on Thursday.

Plus: A biotech turns to wearables and a drug giant beefs up on AI chips.

The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...

Nursing homes misuse antipsychotic drugs for dementia patients, disguise practice as schizophrenia treatment, watchdog finds.

A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval, the company said Thursday, providing it with a new catalyst as it tries to claw back market share with its ...